Effects of Open-label Placebos on COVID-related Psychological Health

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

February 4, 2021

Primary Completion Date

May 5, 2021

Study Completion Date

May 5, 2021

Conditions
StressAnxietyDepression
Interventions
BEHAVIORAL

Non-Deceptive Placebo

"The placebos were ordered through Amazon from Zeebo® (Zeebo, Zeebo Effect, LLC, South Burlington, Vermont, USA). The placebos in this study were blue and white capsules containing Microcrystalline cellulose (an inert fiber). Ingredients include ones that are typically used to make pills including silica, gelatin, titanium dioxide, red #3 food coloring, and blue #1 food coloring. Placebo capsules were free of any active ingredients. These bottles were not branded specifically for the experiment, including the brand name (Zeebo Relief), description of the contents, directions, and a disclaimer. The investigators chose to not include a custom label for transparency and in order to increase non-deceptive placebo effects. Participants were instructed to take two pills a day, one in the morning and one in the evening."

Trial Locations (1)

48823

Michigan State University, East Lansing

All Listed Sponsors
lead

Michigan State University

OTHER

NCT05035550 - Effects of Open-label Placebos on COVID-related Psychological Health | Biotech Hunter | Biotech Hunter